Evome Medical Technologies Inc. (LNDZF)
OTCMKTS · Delayed Price · Currency is USD
0.0040
-0.0410 (-91.11%)
At close: Apr 22, 2025

LNDZF Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '23 Dec '22 Feb '22 Feb '21 Feb '20 2015 - 2019
Market Capitalization
012182444
Upgrade
Market Cap Growth
-38.93%-31.93%-24.49%459.28%15.33%-20.03%
Upgrade
PS Ratio
0.010.270.631.71-164.1115.08
Upgrade
PB Ratio
-0.124.111.622.340.830.53
Upgrade
P/FCF Ratio
0.08-----
Upgrade
P/OCF Ratio
0.08-----
Upgrade
Debt / Equity Ratio
-5.096.170.830.80--
Upgrade
Debt / FCF Ratio
3.25-----
Upgrade
Quick Ratio
0.180.230.280.631.1737.62
Upgrade
Current Ratio
0.510.560.550.872.0238.22
Upgrade
Asset Turnover
0.881.20-0.64-0.03
Upgrade
Return on Equity (ROE)
-294.80%-161.40%--44.17%-33.06%-13.03%
Upgrade
Return on Assets (ROA)
-45.68%-31.11%--15.67%-23.34%-12.72%
Upgrade
Earnings Yield
-5803.14%-94.81%-76.98%-14.23%-48.45%-38.16%
Upgrade
Earnings Yield
-5803.14%-94.81%-76.98%-14.23%-48.45%-38.16%
Upgrade
FCF Yield
1323.84%-6.82%-7.11%-12.24%-17.71%-3.92%
Upgrade
Buyback Yield / Dilution
-28.35%-33.97%-25.70%-29.09%-0.03%-
Upgrade
Total Shareholder Return
-28.35%-33.97%-25.70%-29.09%-0.03%-
Upgrade
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.